Hammel, P., Metges, J., Mercade, T. M., Garcia-Carbonero, R., Bouche, O., Portales, F., Cid, R. A. P., Mineur, L., Gracian, A. C., Trouilloud, I., Guimbaud, R., Tougeron, D., Reina, J. J., Feliu, J., Saurí, T., Fountzilas, C., Lecomte, T., Molin, Y., Ponz-Sarvise, M., Forget, F., Berardi, R., Cutsem, E. V., Gelsomino, F., Tournigand, C., Bockorny, B., Bachet, J. B., Vera, M. M., Cuyle, P., Wasan, H., Noel, M., Laethem, J. V., Kay, R., Youssoufian, H., El-Hariry, I., Hidalgo, M. (2025). TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00872